BR112017026228A2 - método para preparação de imunoglobulina da hepatite b derivada do plasma - Google Patents

método para preparação de imunoglobulina da hepatite b derivada do plasma

Info

Publication number
BR112017026228A2
BR112017026228A2 BR112017026228-2A BR112017026228A BR112017026228A2 BR 112017026228 A2 BR112017026228 A2 BR 112017026228A2 BR 112017026228 A BR112017026228 A BR 112017026228A BR 112017026228 A2 BR112017026228 A2 BR 112017026228A2
Authority
BR
Brazil
Prior art keywords
immunoglobulin
hepatitis
plasma
preparing
derived
Prior art date
Application number
BR112017026228-2A
Other languages
English (en)
Inventor
Won Shin Yong
Il Park Dong
Mo Ahn Chung
Kyung Kim Jong
Hwee Lee Dong
Original Assignee
Green Cross Holdings Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Holdings Corporation filed Critical Green Cross Holdings Corporation
Publication of BR112017026228A2 publication Critical patent/BR112017026228A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A61K39/39525Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002Coronaviridae
    • C07K16/1003Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2 or Covid-19]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Water Supply & Treatment (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

método para preparação de imunoglobulina da hepatite b derivada do plasma a presente invenção refere-se a um método de preparação de uma preparação de imunoglobulina da hepatite b humana derivada do plasma. mais especificamente, refere-se a um método de preparação de uma preparação de imunoglobulina da hepatite b derivada de plasma humano, caracterizada pela fração ii da proteína plasmática (fração ii) contendo imunoglobulina humana contra a hepatite b ser concentrada por diálise e, em seguida, materiais que produzem trombo e impurezas formadas durante os processos serem removidos por técnicas de purificação de resina de troca aniônica e resina de troca catiônica. pela utilização do método proposto, a eficiência de remoção de impurezas e materiais que produzem trombo é aumentada e um conteúdo de polímero é mantido, através do qual é possível produzir imunoglobulina humana contra a hepatite b com a estabilidade e a melhoria da qualidade.
BR112017026228-2A 2015-06-05 2016-06-02 método para preparação de imunoglobulina da hepatite b derivada do plasma BR112017026228A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2015-0080042 2015-06-05
KR1020150080042A KR101657690B1 (ko) 2015-06-05 2015-06-05 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법
PCT/KR2016/005837 WO2016195387A1 (ko) 2015-06-05 2016-06-02 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법

Publications (1)

Publication Number Publication Date
BR112017026228A2 true BR112017026228A2 (pt) 2018-09-11

Family

ID=57102805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017026228-2A BR112017026228A2 (pt) 2015-06-05 2016-06-02 método para preparação de imunoglobulina da hepatite b derivada do plasma

Country Status (7)

Country Link
US (1) US10406223B2 (pt)
EP (1) EP3305800B1 (pt)
JP (1) JP6514412B2 (pt)
KR (1) KR101657690B1 (pt)
CN (1) CN107849086B (pt)
BR (1) BR112017026228A2 (pt)
WO (1) WO2016195387A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
ES2769783T3 (es) * 2014-03-11 2020-06-29 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
KR20190047376A (ko) 2017-10-27 2019-05-08 주식회사 녹십자 개선된 면역글로불린의 정제방법
CN112574296B (zh) * 2020-12-30 2023-05-19 中国医学科学院输血研究所 一种模拟IVIg的多人份混合人血浆IgG样品的分离纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
US4124576A (en) 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
JPS617561A (ja) 1984-06-20 1986-01-14 Toshiba Corp 表示素子用放電灯
DE3624258A1 (de) 1986-07-18 1988-01-21 Basf Ag Verfahren zur herstellung von chlorcarbonsaeurechloriden
DE59009020D1 (de) * 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
JP4685238B2 (ja) * 1998-06-09 2011-05-18 ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
PL196770B1 (pl) * 1998-06-09 2008-01-31 Statens Seruminstitut Sposób oczyszczania immunoglobuliny, produkt immunoglobuliny i jego zastosowanie
KR20150008503A (ko) * 2007-10-30 2015-01-22 제넨테크, 인크. 양이온 교환 크로마토그래피에 의한 항체 정제
CN104004090A (zh) * 2014-06-12 2014-08-27 新疆德源生物工程有限公司 一种人免疫球蛋白的制备方法
CN104001172B (zh) * 2014-06-12 2016-02-24 新疆德源生物工程有限公司 一种静脉注射用乙型肝炎人免疫球蛋白的制备工艺
CN104231075B (zh) * 2014-09-02 2017-03-22 江西博雅生物制药股份有限公司 一种乙型肝炎人免疫球蛋白的制备工艺

Also Published As

Publication number Publication date
EP3305800B1 (en) 2024-02-28
US20180140699A1 (en) 2018-05-24
EP3305800C0 (en) 2024-02-28
EP3305800A4 (en) 2018-12-19
KR101657690B1 (ko) 2016-09-19
WO2016195387A1 (ko) 2016-12-08
JP2018528249A (ja) 2018-09-27
US10406223B2 (en) 2019-09-10
EP3305800A1 (en) 2018-04-11
JP6514412B2 (ja) 2019-05-15
CN107849086A (zh) 2018-03-27
CN107849086B (zh) 2022-02-01

Similar Documents

Publication Publication Date Title
BR112017026228A2 (pt) método para preparação de imunoglobulina da hepatite b derivada do plasma
BR112016024632A2 (pt) métodos de purificação de rna mensageiro
AR090552A1 (es) Procedimiento de separacion y recuperacion de metales alcalinos y aparato de separacion y recuperacion de metales alcalinos
BR112016029906A2 (pt) compostos excipientes redutores de viscosidade para formulações proteicas
BR112012006912A8 (pt) Hipervesiculação de cepas de shigella
EA201291061A1 (ru) Способ получения изотопа
SG10201811186XA (en) Purification of proteins
MX2021010060A (es) Produccion de virus en huevos aviares.
BR112016015718A2 (pt) Processo de purificação de aminoácidos aromáticos
AR111858A1 (es) Método para suavizar solución salina de litio utilizando nanofiltración
CL2016002073A1 (es) Proceso para producir una solución inyectable de noradrenalina de baja concentración estable
EA201690958A1 (ru) Депрессанты для применения в способах разделения
BR112014019872B8 (pt) Método para concentrar celulose nanofibrilar, uso de um aparelho de filtração por pressão, e, produto de celulose de fibrila concentrado
EA201691563A1 (ru) Сухой кислотный концентрат в гранулированной форме
BR112017028128A2 (pt) ?processo para a preparação de uma poliamida?
AR086461A1 (es) Procedimiento de separacion y recuperacion de metal alcalino y aparato de separacion y recuperacion de metal alcalino
AR100131A1 (es) Proceso de purificación de gonadotropina
BR112016022508A2 (pt) anticorpos contra hpa-1a
MX2018000829A (es) Resinas quelantes que contienen grupos de acido iminoacetico dopadas con aluminio.
EP3366641A4 (en) METHOD FOR PRODUCING A CLEANED AQUEOUS SOLUTION OF SILICA
ES2721311T3 (es) Procedimiento de preparación de inmunoglobulinas
MX2015008901A (es) Método para extraer ácido ferúlico y/o sales del mismo.
SA518391325B1 (ar) عمليات لإنتاج حمض أسيتيك
BR112015004950A2 (pt) processo para preparar uma suspensão de proteína estabilizada
BR112018010558A2 (pt) estimulação de transcrição da autofagia melhora a capacidade adaptativa de plantas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]